Cyhoeddiadau
Campbell MD, Sathish T, Zimmet PZ, Thankappan KR, Oldenburg B, Owens DR, Shaw JE, Tapp RJ. Benefit of lifestyle-based T2DM prevention is influenced by prediabetes phenotype Nat Rev Endocrinol. 2020 Feb 14. doi: 10.1038/s41574-019-0316-1.
Zayed MG, Bain SC A man with nodules on the backs of his hands Diabet Med. 2020 Feb 10. doi: 10.1111/dme.14269
Kew JL, Bain SC An unusual skin rash in a person with type 1 diabetes Diabet Med. 2020 Feb 5. doi: 10.1111/dme.14263
Min T, Bain SC. Estimands in diabetes clinical trials. Estimands in diabetes clinical trials. Lancet Diabetes Endocrinol. 2020 Jan 20. pii: S2213-8587(19)30407-3. doi: 10.1016/S2213-8587(19)30407-3.
Owens DR, Bolli GB The continuing quest for better subcutaneously administered prandial insulins: a review of recent developments and potential clinical implications Diabetes Obes Metab. 2020 Jan 13. doi: 10.1111/dom.13963.
Williams DR, Parsons SN, Dunseath GJ, Stephens JW, Luzio SD, Owens DR. The impact of structured self-monitoring of blood glucose on glycaemic variability in non-insulin treated type 2 diabetes: The SMBG study, a 12-month randomised controlled trial. Diabetes Metab Syndr. 2020 Jan 13;14(2):101-106. doi: 10.1016/j.dsx.2020.01.006. [Epub ahead of print] PMID: 31995784 doi: 10.1016/j.dsx.2020.01.006.
Bain SC, Hansen BB, Malkin SJP, Nuhoho S, Valentine WJ, Chubb B, Hunt B, Capehorn M. Oral Semaglutide Versus Empagliflozin, Sitagliptin and Liraglutide in the UK: Long-Term Cost-Effectiveness Analyses Based on the PIONEER Clinical Trial Programme. Diabetes Ther. 2020 Jan;11(1):259-277. doi: 10.1007/s13300-019-00736-6
Husain M, Bain SC, Jeppesen OK, Lingvay I, Sørrig R, Treppendahl MB, Vilsbøll T Semaglutide (SUSTAIN and PIONEER) reduces cardiovascular events in type 2 diabetes across varying cardiovascular risk. Diabetes Obes Metab. 2020 Jan 5. doi: 10.1111/dom.13955.
Min T, Prior SL, Dunseath G, Churm R, Barry JD, Stephens JW Temporal Effects of Bariatric Surgery on Adipokines, Inflammation and Oxidative Stress in Subjects with Impaired Glucose Homeostasis at 4 Years of Follow-up Obes Surg. 2020 Jan 3. doi: 10.1007/s11695-019-04377-3.
Husain M, Donsmark M, Bain SC. Oral Semaglutide and Cardiovascular Outcomes in Type 2 Diabetes. Reply. N Engl J Med. 2019 Nov 21;381(21):2076-2077. doi: 10.1056/NEJMc1913157. No abstract available. PMID: 31747740